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Abstract
Introduction Prolonged critically ill patients reveal low
circulating thyroid hormone levels without a rise in thyroid
stimulating hormone (TSH). This condition is labeled "low 3,5,3'-
tri-iodothyronine (T3) syndrome" or "nonthyroidal illness
syndrome (NTI)" or "euthyroid sick syndrome". Despite the low
circulating and peripheral tissue thyroid hormone levels,
thyrotropin releasing hormone (TRH) expression in the
hypothalamus is reduced and it remains unclear which
mechanism is responsible. We set out to study whether
increased hypothalamic T3  availability could reflect local
thyrotoxicosis and explain feedback inhibition-induced
suppression of the TRH gene in the context of the low T3
syndrome in prolonged critical illness.
Methods Healthy rabbits were compared with prolonged
critically ill, parenterally fed animals. We visualized TRH mRNA
in the hypothalamus by in situ-hybridization and measured
mRNA levels for the type II iodothyronine diodinase (D2), the
thyroid hormone transporters monocarboxylate transporter
(MCT) 8, MCT10 and organic anion co-transporting polypeptide
1C1 (OATP1C1) and the thyroid hormone receptors α (TRα)
and β (TRβ) in the hypothalamus. We also measured the activity
of the D2 and type III iodothyronine deiodinase (D3) enzymes.
Results In the hypothalamus of prolonged critically ill rabbits
with low circulating T3 and TSH, we observed decreased TRH
mRNA, increased D2 mRNA and increased MCT10 and
OATP1C1 mRNA while MCT8 gene expression was unaltered
as compared with healthy controls. This coincided with low
hypothalamic thyroxine (T4) and low-normal T3 concentrations,
without a change at the thyroid hormone receptor level.
Conclusions Although expression of D2 and of the thyroid
hormone transporters MCT10 and OATP1C1 were increased in
the hypothalamus of prolonged critical ill animals, hypothalamic
T4 and T3 content or thyroid hormone receptor expression were
not elevated. Hence, decreased TRH gene expression, and
hereby low TSH and T3 during prolonged critical illness, is not
exclusively brought about by hypothalamic thyrotoxicosis, and
infer other TRH suppressing factors to play a role.
Introduction
Prolonged critically ill patients reveal a suppressed neuroen-
docrine function with low circulating levels of several anterior
pituitary-dependent hormones [1]. The severity of these neu-
roendocrine alterations was shown to be related to adverse
outcome of patients in the intensive care unit [1,2].
bp: base pair; BSA: bovine serum albumin; CV: coefficient of variation; D1: type 1 iodothyronine deiodinase; D2: type 2 iodothyronine deiodinase; 
D3: type 3 iodothyronine deiodinase; HPRT: hypoxanthine guanine phosphoribosyl transferase; HPT: hypothalamus-pituitary-thyroid; MCT: monocar-
boxylate transporter; OATP: organic anion transporting polypolypeptide; PCR: polymerase chain reaction; PN: parenteral nutrition; PVN: paraventricu-
lar nucleus; RIA: radioimmunoassay; T3: 3,5,3'-triiodothyronine; T4: thyroxine; TR: thyroid hormone receptor; TRH: thyrotropin releasing hormone; 
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The thyroid axis is driven by thyrotropin releasing hormone
(TRH) from the paraventricular nucleus (PVN) of the hypotha-
lamus. TRH stimulates the release of thyroid stimulating hor-
mone or thyrotropin (TSH) from the pituitary, which in turn
drives the thyroid gland to produce and release the prohor-
mone thyroxine (T4) and to a minor extent the active hormone
3,5,3'-triiodothyronine (T3). T4 is metabolized in peripheral tis-
sues to produce T3. There is a typical negative feedback reg-
ulation from T3 and T4 at the level of the pituitary and the
hypothalamus. During prolonged critical illness, circulating T3
levels are low and in severe and prolonged cases, T4 levels are
also reduced [3]. This condition is referred to as the 'low T3
syndrome', the 'non-thyroidal illness syndrome' or the 'euthy-
roid sick syndrome', different names that reflect the uncer-
tainty regarding its origin and clinical implications. Despite the
low levels of circulating and peripheral tissue thyroid hor-
mones, TRH expression in the hypothalamus is reduced [4]
and the TSH secretory pattern shows a dramatic loss in pulsa-
tility, which correlates positively with the low serum T3 concen-
trations [1,3]. The reduced TSH release seems to be
secondary to the diminished drive by TRH [1]. It remains
unclear which mechanism is responsible for the reduced
hypothalamic TRH expression during prolonged critical illness.
Several mechanisms have been proposed for the suppression
of the hypothalamus-pituitary-thyroid (HPT) axis during critical
illness, among which is a local thyrotoxicosis in the hypothala-
mus. Increased hypothalamic T3  availability could indeed
explain feedback inhibition-induced suppression of the TRH
gene in the context of the low T3 syndrome. A first mechanism
for increasing the local concentration of T3 in the hypothala-
mus is increased local conversion of T4 to T3. More than 80%
of T3 in the brain originates from local T4 to T3conversion by the
type II iodothyronine deiodinase (D2) [5]. Therefore, an upreg-
ulation of D2 in the mediobasal hypothalamus could lead to a
local hyperthyroid state which in turn would suppress TRH in
hypophysiotropic neurons. Injection of lipopolysacharide in
rats and mice has been shown to upregulate hypothalamic D2
expression and activity [6-9]. Alternatively, decreased inactiva-
tion of T3 and T4 by the type III iodothyronine deiodinase (D3)
could also lead to higher hypothalamic thyroid hormone levels
suppressing TRH. In line with this, a mouse model for chronic
inflammation showed decreased D3 mRNA expression in the
region of the hypothalamic PVN [10].
A second possible mechanism by which local iodothyronine
levels in the hypothalamus could be increased is elevated
transport of iodothyronines into the hypothalamus. The entry of
thyroid hormone from the circulation into the hypothalamus is
mediated by specific thyroid hormone transporters of which
two categories have been identified, organic anion transport-
ers and amino acid transporters. Na+-independent organic
anion co-transporting polypeptides (OATPs) represent a large
family of homologous proteins of which OATP1C1
(SLCO1C1) shows a high specificity and affinity towards
iodothyronines, in particular T4 and reverse T3 (rT3) [11,12].
OATP1C1 is mainly expressed in brain capillaries and is con-
sidered to be important for the uptake of T4 across the blood-
brain barrier [11-13]. The human monocarboxylate transporter
8 (MCT8), a specific thyroid hormone transporter, is also
expressed in the hypothalamus and transports T4 and T3 in a
Na+-independent manner [14]. Study of MCT8 null-mice sug-
gests that its expression is necessary for normal feedback reg-
ulation of TRH neurons in the hypothalamus [15,16]. MCT10
was identified as a T-type amino-acid transporter [17,18] and
was recently shown to be at least as active for thyroid hormone
transport as MCT8 [19]. The role of these transporters in
hypothalamic feedback regulation in critically ill patients is cur-
rently unknown.
The major effects of thyroid hormone are exerted by interaction
with its nuclear receptors. Thereby, a third mechanism explain-
ing a lower TRH expression in the face of normal or low thyroid
hormone levels could be an increased activity of the available
thyroid hormone by increasing the expression of the nuclear
thyroid hormone receptors. No data on hypothalamic expres-
sion of the different thyroid hormone receptors in prolonged
critical illness are currently available.
Our goal was to study if increased local T3 content in the
hypothalamus, brought about by these different potential
mechanisms, suppresses hypophysiotropic TRH neurons dur-
ing prolonged critical illness.
Materials and methods
In vivo animal experiment
All animals were treated according to the Principles of Labora-
tory Animal Care formulated by the U.S. National Society for
Medical Research and the Guide for the Care and Use of Lab-
oratory Animals prepared by the National Institutes of Health.
The study protocol was approved by the Leuven University
ethical review board for animal research (P03052).
The model has been described in detail previously and is
shown to reproduce the bi-phasic response to critical illness
as seen in the human situation [20,21].
Male New Zealand White rabbits were housed individually and
exposed to artificial light for 14 hours per day. On day 1, rab-
bits were anesthetized with 30 mg/kg ketamine, intramuscu-
larly (Merial, Lyon, France), and 0.15 mg/kg medetomidine,
intramuscularly (Orion, Ospoo, Finland). Their neck and flanks
were shaved and anesthesia was than supplemented by isoflu-
rane (Isoba Vet.; Schering-Plough, Brussels, Belgium) added
to the breathing gas via regular vaporizer. Thereafter, a supple-
mental local paravertebral block with xylocaine 1% (Astra
Pharmaceuticals, Brussels, Belgium) was performed and a
full-thickness burn injury equaling 15 to 20% total body sur-
face area was imposed. At the end of the procedure, animals
returned to their cages where overnight fluid resuscitation wasAvailable online http://ccforum.com/content/13/5/R147
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started with a continuous infusion of Ringer's lactate at six
drops per minute (± 18 ml/h) through a volumetric infusion
pump (IVAC 531 infusion pump, IVAC cooperation, San
Diego, CA, USA). All animals received parenteral nutrition
(PN) from day 2 onwards to avoid starvation-induced endo-
crine alterations. The PN infusion bags contained 150 ml of
Clinomel N7 (Baxter, Clintec Parentéral, Maurepas, France)
and 175 ml sterile water. Thus, bags with 325 ml solution con-
tained 156 kcal non-protein calories and 0.99 g nitrogen. Of
all non-protein calories, 61.5% were delivered as carbohy-
drates, and 38.5% as fat. Protein intake equaled 1.49 g/kg per
day. No additional vitamins or trace elements were added. PN
was infused at four drops a minute (± 12 ml/h). Animals had
free access to water, but oral food intake was denied. Blood
glucose levels were kept below 180 mg/dl by frequent blood
glucose monitoring and titration of insulin infusion (100 IU/ml;
Actrapid Novolet, Novo Nordisk, Bagsvaerd, Denmark; via an
SE200B infusion pump, Vial Medical, Brezins, France) when
necessary. In total, 25 animals survived 7 days of illness, after
which blood was taken and serum was stored at -20°C. Ani-
mals were sacrificed and a tissue block containing the hypoth-
alamus (rostral border just anterior of the optic chiasm, caudal
border through the mamillary bodies, dorsal border through
septum) was dissected and snap-frozen in liquid nitrogen.
Healthy animals (n = 25), matched for gender, age, and body
weight, that had free access to regular chow, were studied as
controls.
Serum analysis
Plasma concentrations of TSH were measured by a specific
radioimmunoassay (RIA; reagents provided by Dr. A. Parlow,
National Pituitary Agency). The detection limit was 1.2 mIU/l,
and the intra assay coefficient of variation (CV) was 5.3%. In
one sample from a prolonged ill rabbit TSH was below the
detection limit. Total concentrations of plasma T4 and T3 were
determined by an in-house RIA [22]. The detection limit and
intra assay CV were, 5 and 2 fmol and 2.8% and 2.2%,
respectively. No free hormone determinations were performed
because blood sampling was performed with heparinized
catheters which is known to artefactually alter the free fraction
of thyroid hormones in the samples [23].
D2 and D3 activity
The complete hypothalamic block of five control animals and
six prolonged ill rabbits were homogenized on ice in 10 vol-
umes of PED10 buffer (0.1 M phosphate, 2 mM EDTA, 10 mM
DTT, pH 7.2) using a Polytron (Kinematica AG, Lucerne, Swit-
zerland). Homogenates were cooled on ice and immediately
analyzed. Protein concentration was measured with the Bio-
Rad Protein Assay (Bio-Rad, Veenendaal, The Netherlands)
using BSA as the standard following the manufacturer's
instructions. D2 and D3 activities were assayed [24] by dupli-
cate incubations of homogenate (final protein concentration
about 4 mg/ml) for 60 minutes at 37°C with 1 nM [3',5'-125I]T4
(200,000 cpm) in a final volume of 0.1 ml PED10 buffer. The
incubations were carried out in the presence of 0.1 mM pro-
pylthiouracil to inhibit possible D1 activity, and in the absence
or presence of 0.1 μM T3 to saturate D3 activity. Reactions
were stopped by addition of 0.1 ml 100% methanol on ice.
After centrifugation, 0.1 ml of the supernatant was added to
0.1 ml 0.02 M ammonium acetate (pH 4.0), and 0.1 ml of the
mixture was applied to a 4.6 × 250 mm Symmetry C18 column
connected to an Alliance high-performance liquid chromatog-
raphy system (Waters, Etten-Leur, The Netherlands). The col-
umn was eluted with a linear gradient of acetonitrile (28 to
42% in 15 minutes) in 0.02 M ammonium acetate (pH 4.0) at
a flow of 1.2 ml/min. The radio-activity in the eluate was meas-
ured on-line using a Radiomatic A-500 flow scintillation detec-
tor (Packard, Meriden, CT, USA). Activity eluting in the T3 and
rT3 fractions represented D2 and D3 activity, respectively.
Thyroid hormone concentration in the hypothalamus
We used the hypothalamic block of 10 healthy rabbits and 11
prolonged critically ill rabbits to measure T4 and T3 content.
Iodothyronines were extracted and purified from the hypotha-
lamus and T4 and T3 were measured by RIA, as described pre-
viously [25,26]. In brief, the entire hypothalamic block was
homogenized directly in methanol, and 2000 cpm of outer ring
labeled [131I]T4 and [125I]T3 were added to each sample as
internal tracers for recovery. Appropriate volumes of chloro-
form were added to extract with chloroform/methanol (2:1)
twice. The iodothyronines were then back-extracted into an
aqueous phase and purified by passing this aqueous phase
through Bio-Rad AG 1 × 2 resin columns (Bio-Rad,
Veenendaal, The Netherlands). After a pH gradient, the
iodothyronines were eluted with 70% acetic acid, evaporated
to dryness, and resuspended in RIA buffer. The extracts were
counted to determine the recovery of [131I]T4 and [125I]T3
added to each sample. For the present experiment the average
recovery was 50.5% for [131I]T4, and 74.5% for [125I]T3. Con-
centrations were calculated using the amounts of T4 and T3
found in the respective RIAs, the individual recovery of [131I]T4
and [125I]T3 added to each sample, and the weight of the tis-
sue sample submitted for extraction.
Cloning of rabbit genes
Total RNA was isolated from rabbit hypothalamic tissue using
Qiazol lysis reagent (Qiagen, Venlo, The Netherlands) and
subsequently purified using the RNeasy mini RNA isolation kit
(Qiagen, Venlo, The Netherlands). cDNA was obtained by
reverse transcription of 2 μg total RNA using random hexamer
primers. Oligonucleotides homologous to sequences sur-
rounding the start or stop codons of human, mouse and rat
proTRH, D2, MCT8, MCT10, OATP1C1, thyroid hormone
receptor (TR) α1, TRα2, TRβ1 and TRβ2 were designed and
used for PCR. The amplified fragments were cloned into the
pGEM-T vector followed by sequence analysis. These
sequences showed high amino acid identity with the corre-
sponding genes from other mammalian species and data have
been submitted to the GenBank database: proTRHCritical Care    Vol 13 No 5    Mebis et al.
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[GenBank:EF370408], D2 [GenBank:EU489480], MCT8
[GenBank:EF420874], MCT10 [GenBank:EF489851],
OATP1C1 [GenBank:EF420875], TRα1 [Gen-
Bank:EU489476], TRα2 [GenBank:EU489477], TRβ1 [Gen-
Bank:EU489478] and TRβ2 [GenBank:EU489479]. Based
on these sequences, we designed specific primers and
probes for real-time PCR analysis and in situ hybridization.
Fluorescence in situ hybridization
TRH and D2 mRNA expression was analyzed in two healthy vs.
two prolonged ill animals. The TRH and D2 in situ probes were
generated in our laboratory. The TRH probe was complemen-
tary to 1 to 203 bp of the rabbit proTRH mRNA sequence
(EU489480), and the D2 probe was complementary to 3230
to 608 bp of the rabbit type II deiodinase gene (EF370408).
The fluorescent in situ hybridization protocol was adapted
from a standard in situ hybridization protocol of the TSA™
Biotin System (New England Nuclear, Boston, MA). The anti-
sense RNA probes were digoxin/digoxigenin labeled, diluted
in hybridization buffer and hybridized on 10 μm tissue cryosec-
tions overnight in a humidified stove at 62°C. After washing,
the sections were incubated with an anti-digoxin/digoxigenin
horseradish peroxidase-labeled antibody. The probe was
amplified using Tyramide Amplification Reagent (TSA™ Biotin
System, NEN, Boston, MA), and visualized with streptavidine
conjugated to Cy3. Following washes, the sections were
mounted in Fluorescent Mounting Medium (DAKO, Glostrup,
Denmark) with 4',6-diamidino-2-phenylindole (Sigma-Aldrich,
Bornem, Belgium) to counter stain cell nuclei. We analyzed
sense-probes as negative controls. As it is not possible to
quantitate data obtained from fluorescent in situ hybridization
with tyramide amplification, we attempted to do isotopic in situ
hybridizations. This resulted in high background and low signal
to noise ratio and results could not be used for analysis.
RNA isolation and real-time PCR
Gene expression analysis was performed on eight healthy rab-
bits vs. six prolonged ill animals. RNA was isolated from the
total hypothalamic block using the RNeasy midi RNA isolation
kit (Qiagen, Venlo, The Netherlands) and quantified by Nano-
drop spectrophotometer (ND-1000, Nanodrop Technologies,
Wilmington, DE, USA). Samples were treated with DNAse to
remove all contaminating genomic DNA. A 1 μg sample of
total RNA was reverse-transcribed using random hexamers. All
samples were reverse transcribed simultaneously. Reactions
lacking reverse transcriptase were also run as a control for
genomic DNA contamination.
D2, MCT8, MCT10, OATP1C1, TRα1, TRα2, TRβ1 and TRβ2
mRNA levels were quantified in real time with the ABI PRISM
7700 sequence detector (Applied Biosystems, Foster City,
CA) which uses TaqMan chemistry for highly accurate quanti-
zation of mRNA levels. Sequences of the primers and probes
are given in Table 1. The 10 μl real-time reaction mixture con-
tained 5 μl TaqMan® Fast Universal PCR Master Mix (Applied
Biosystems, Foster City, CA), 0.5 μl forward primer (18 μM),
0.5 μl reverse primer (18 μM), 0.5 μl TaqMan probe ([5']6-
FAM [3']BHQ-1 labeled) (6 μM), 0.5 μl water and 3 μl cDNA
(7.5 ng). Unknown samples were run in duplicate and individ-
ual samples with a Ct value standard deviation greater than
0.3 were reanalyzed. Data were analyzed using the compara-
tive Ct method. The rabbit hypoxanthine guanine phosphori-
bosyl transferase (HRPT) gene was first cloned and absolute
quantification was performed using a standard curve. This
showed no significant difference between healthy control and
prolonged ill rabbits. HPRT was therefore used as an internal
control.
Statistical analysis
All statistical analyses were done using StatView software
(SAS Institute Inc., Cary, NC, USA). Data were analyzed using
one-way analysis of variance tests. Data are presented as
mean ± standard deviation. Statistical significance was
assumed for a two sided P < 0.05.
Results
As described previously [21], this rabbit model of prolonged
critical illness is characterized by low T3 plasma concentra-
tions in the face of decreased TSH levels (Figure 1).
TRH is expressed at different sites in the hypothalamus; there-
fore, measuring TRH expression in homogenates of the total
hypothalamic block would not selectively reflect hypophysio-
tropic TRH expression. We therefore used in situ hybridization
histochemistry to visualize TRH mRNA expression and
observed markedly reduced hybridization signal in the PVN of
prolonged ill animals confirming the prolonged critically ill state
of our animals. (Figures 2a, a', b and 2b').
D2 mRNA expression by in situ hybridization showed to be
strongly increased in the mediobasal hypothalamus of pro-
longed ill animals, mostly in the floor and infralateral walls of
the third ventricle (Figures 2b, b'). This increase was con-
firmed by quantitative real-time PCR measurement (P = 0.03;
Figure 3). D2 activity tended to be increased in sick rabbits but
this did not reach significance (prolonged ill rabbits 0.14 ±
0.09 vs. healthy controls 0.09 ± 0.02, P = 0.25; Figure 3).
Incubation of hypothalamic homogenates with [125I]T4  as
described in Materials and Methods resulted in a 30 to 50%
conversion of the substrate to [125I]rT3. Reverse T3 production
was inhibited more than 80% by addition of 0.1 μM T3 to the
incubation mixture, confirming that this represents D3 activity.
D3 activity was not significantly different but tended to be
higher in chronically ill rabbits (prolonged ill rabbits 1.63 ±
0.45 fmol/min/mg protein vs. healthy controls 1.24 ± 0.34; P
= 0.14).
Expression levels of thyroid hormone transporters MCT10 (P
= 0.04) and OATP1C1 (P  = 0.002) were significantlyAvailable online http://ccforum.com/content/13/5/R147
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increased in the hypothalamus of prolonged ill animals (Figure
4a). There was no change in MCT8 gene expression (Figure
4a).
Hypothalamic TRα1, TRα2, TRβ1 and TRβ2 expression was
not significantly different in prolonged ill animals as compared
with healthy controls (Figure 4b).
In prolonged ill rabbits, we measured a 40% reduction in
hypothalamic T4 content as compared with healthy rabbits (P
= 0.03, Figure 5). T3 content was not significantly different
between the two groups, but tended to be lower in the criti-
cally ill animals (P = 0.17, Figure 5).
Discussion
Prolonged critical illness is hallmarked by reduced TRH gene
expression in the face of low circulating T3 levels. In our animal
model of prolonged critical illness, we investigated whether
reduced TRH could be the result of feedback inhibition
exerted by increased local T3 levels in the hypothalamus. We
found increased D2 mRNA and increased thyroid hormone
transporter gene expression (MCT10 and OATP1C1) in pro-
longed critically ill animals. These changes could lead to
increased local T3 levels supporting our hypothesis. However,
local T4 levels in the hypothalamus were lower in the critically
ill than in healthy control animals, whereas local T3 levels were
Table 1
Real-time polymerase chain reaction primers and probes
Gene name [Genbank accession number] Sequence
ocD2 [GenBank:EF370408] Forward: 5'-GGACTCCGCTGTGTCTGGAA-3'
Probe: 5'-CTTGACGCCTACAAACA-3'
Reverse: 5'-GGCATCCTCGCCCAATTT-3'
ocMCT8 [GenBank:EF420874] Forward: 5'-CCATGTGGCCTTCTACTTTGC-3'
Probe: 5'-CCCCCCATCATTGGAGCTGTCATC-3'
Reverse: 5'-TGCATCAGAGGGACGAAGAAA-3'
ocMCT10 [Genbank:EF489851] Forward: 5'-TCCGAGCAGAAATCCAATCG-3'
Probe: 5'-TTGGGACACATCCCGGGCACC-3'
Reverse: 5'-GGCTCCCATTGCCTTTGAG-3'
ocOATP1C1 [GenBank:EF420875] Forward: 5'-GATCAGCGGTCTTTGGTTACCT-3'
Probe: 5'-CTGTTCCTTTCCCTGTTTGCACTGGG-3'
Reverse: 5'-TGCCACATCCAAGTTTTCACA-3'
ocTRα1 [GenBank:EU489476] Forward: 5'-GAGTGCCCCACCGAACTCT-3'
Probe: 5'-TCCCCCACTCTTCCTCGAGGTCTTTG-3'
Reverse: 5'-CCGCCTGAGGCTTTTAGACTT-3'
ocTRα2 [GenBank:EU489477] Forward: 5'-AAGTGCAGAGTTCGATTCTGTACAA-3'
Probe: 5'-CGGGTCACTGGGCGTCCACC-3'
Reverse: 5'-GAACAACATGCATTCCGAGAAG-3'
ocTRβ1 [GenBank:EU489478] Forward: 5'-GCGCAGCGCGTTGAA-3'
Probe: 5'-AACGAACAGTCATCACCACATCTCATCCAG-3'
Reverse: 5'-GGATGGAGCTCGTCCAAGTG-3'
ocTRβ2 [GenBank:EU489479] Forward: 5'-GCCATCCTGACTATTTCACTGAAGA-3'
Probe: 5'-AAGCCTACTTTTTCTCAAGGGCAGTCACCG-3'
Reverse: 5'-GGGATGTACCCTTTTTTCTGAGAGT-3'
ocHPRT [GenBank:AF020294] Forward: 5'-TGTAGATTTTATCAGACTGAAGAGCTACTGT-3'
Probe: 5'-TTTCCAGTTAAGGTTGAGAGATCATCTCCACCGAT-3'
Reverse: 5'-AAGGAAAGCAAGGTCTGCATTGTT-3'Critical Care    Vol 13 No 5    Mebis et al.
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similar. There was no change at the thyroid hormone receptor
level.
By in situ hybridization staining we observed an almost com-
plete loss of TRH signal in the PVN of prolonged ill animals.
This confirms data from Fliers and colleagues who have clearly
shown that TRH is reduced during prolonged critical illness
[4].
D2 gene expression was markedly increased in the medioba-
sal hypothalamus in the prolonged critically ill state as was
seen by in situ hybridization staining. This was confirmed when
we quantified D2 gene expression levels with real-time PCR.
We could not measure a significant difference in D2 activity
levels although they seemed to have increased in prolonged
critically ill animals. It is possible that this is due to a dilution
effect because we measured deiodinases activity in the entire
Figure 1
Circulating hormone parameters in healthy control (n = 10) and prolonged ill rabbits (n = 11) Circulating hormone parameters in healthy control (n = 10) and prolonged ill rabbits (n = 11). Data are expressed as mean ± standard deviation. TT3 
= Total T3; TT4 = Total T4; TSH = thyroid stimulating hormone.
Figure 2
Fluorescence in situ hybridization staining for (a, a') TRH, and (b, b') D2 on frozen sections of the hypothalamus Fluorescence in situ hybridization staining for (a, a') TRH, and (b, b') D2 on frozen sections of the hypothalamus. (a, b) Healthy control vs. (a', b') 
prolonged ill animals. (a, a') Magnification × 5, (b, b') × 10. D2 = type II iodothyronine diodinase; PVN = paraventricular nucleus; TRH = thyrotropin 
releasing hormone. Arrows represent third ventricle.Available online http://ccforum.com/content/13/5/R147
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hypothalamic block. However, these results are very similar to
those observed in hypothyroid animals where D2 gene expres-
sion was also found to be moderately increased without an
overt increase in D2 activity [7]. In contrast, fasting has shown
to evoke a more robust increase in D2 mRNA as well as activ-
ity levels [7]. A starvation-induced rise in D2 can be excluded
in our model because all animals were fed via the parenteral
route which guaranteed uptake of the delivered calories
despite the anorexia accompanying illness. As Fekete and
Lechan stated, relatively stable levels of D2 activity in the
mediobasal hypothalamus is necessary for normal negative
feedback regulation of the HPT axis. This allows hypophysio-
tropic TRH neurons to sense any changes in circulating T4 lev-
els [27].
A decrease in D3 activity is another possibility to increase
local T3 levels. Hypothalamic D3 activity, however, showed an
opposite change, because it was not reduced and even
tended to be higher in sick animals.
We examined the expression of thyroid hormone transporters
because an elevated transport of iodothyronines into the
hypothalamus could also contribute to increased local T3 lev-
els. MCT8 is expressed by neurons of the PVN, supraoptic,
and infundibular nuclei [28] and analysis of two different
knockout models showed the importance of MCT8 for thyroid
hormone entry into the brain [15,16]. We observed no signifi-
cant change in MCT8 gene expression during prolonged criti-
cal illness in our rabbit model. However, we measured an
increase in MCT10 and OATP1C1 mRNA levels. Ramadan
and colleagues showed low gene expression levels of MCT10
in total brain RNA extracts [29]. We are the first to show spe-
cific hypothalamic MCT10 expression. It was only very recently
that MCT10 was shown to be a very active transporter of T3
and, to a lesser extent, of T4 [19]. The T4-specific transporter
OATP1C1 was previously shown to be regulated by thyroid
hormone [13]. In hypothyroid rats, the expression of
OATP1C1 is increased in brain capillaries and, conversely,
hyperthyroid rats show decreased expression of this trans-
porter. Regulation of OATP1C1 can thus be an adaptive
response to protect hypothalamic thyroid hormone levels
against fluctuating plasma levels.
Increased expression of thyroid hormone receptors is another
way to increase thyroid hormone activity and thereby reducing
TRH expression in the face of normal or low hypothalamic thy-
roid hormone levels, and expression of thyroid hormone recep-
tor isoforms was shown to be regulated by thyroid hormone
status in the hypothalamus [30]. However, our results did not
support such a mechanism, because the expressions of TRα1,
TRα2, TRβ1 and TRβ2 were unaltered in prolonged critically
ill animals as compared with those in healthy controls.
Increased expression of D2 and increased expression of thy-
roid hormone transporters, as we observed in the prolonged
critically ill rabbits, could theoretically lead to increased local
T3 levels, explaining the suppressed TRH gene expression and
the low circulating TSH levels. However, unexpectedly, local
T3 concentrations were not increased and even tended to be
low and hypothalamic T4 content was significantly reduced in
prolonged ill animals. Data on local levels of thyroid hormones
in the hypothalamus during prolonged critical illness are
Figure 3
Relative D2 mRNA expression levels and D2 activity measured in the whole hypothalamus of healthy rabbits and prolonged ill rabbits Relative D2 mRNA expression levels and D2 activity measured in the whole hypothalamus of healthy rabbits and prolonged ill rabbits. Healthy rab-
bits: n = 5 for activity, n = 8 for expression values; prolonged ill rabbits: n = 6 for activity, n = 6 for expression values. Data are expressed as mean ± 
standard deviation. D2 = type II iodothyronine diodinase.Critical Care    Vol 13 No 5    Mebis et al.
Page 8 of 10
(page number not for citation purposes)
scarce. A study by Arem and colleagues showed that the
hypothalamus of patients who died after chronic severe illness
contains less than half the concentration of T3 as compared
with patients who died from an acute trauma [31], which is in
line with our data. There are two possible ways to interpret our
findings. Because we measured iodothyronine concentrations
in the entire hypothalamic block, we cannot exclude a dilution
effect. Alternatively, local thyroid hormone content in the
hypothalamus could indeed be low during prolonged critical ill-
ness. In that case, other mechanisms inferentially are respon-
sible for reducing TRH gene expression during prolonged
critical illness and the increased D2 and increased thyroid hor-
mone transporter gene expression levels which we observed
could reflect a compensatory response to a local hypothyroid
state. Such a compensatory response would be in line with the
upregulated D2 expression and activity documented in skele-
tal muscle of prolonged critically ill patients [32].
Some limitations of our study should be addressed. Our ani-
mal model of burn injury-induced critical illness may mirror only
Figure 4
Relative mRNA expression of thyroid hormone transporters and thyroid hormone receptors measured in hypothalamus of healthy control and pro- longed ill rabbits Relative mRNA expression of thyroid hormone transporters and thyroid hormone receptors measured in hypothalamus of healthy control and pro-
longed ill rabbits. (a) Thyroid hormone transporters measured were MCT8, MCT10 and OATP1C1 and (b) thyroid hormone receptors measured 
were TRα1, TRα2, TRβ1 and TRβ2 in hypothalamus of healthy control (n = 8) and prolonged ill rabbits (n = 6). Data are expressed as mean ± stand-
ard deviation.Available online http://ccforum.com/content/13/5/R147
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part of the complex entity of human critical illness, and thus
extrapolating to the human situation or to other illnesses
should be done with great caution. Secondly, we were only
able to measure gene expression levels of thyroid hormone
receptors and transporters. This does not necessarily reflect
transporter activity levels.
Conclusions
In conclusion, although hypothalamic D2 mRNA and gene
expression of the thyroid hormone transporters MCT10 and
OATP1C1 were increased in our animal model of prolonged
critical illness, we failed to detect an increase in local T3 levels.
This suggests that the reduced hypothalamic TRH expression
in our animal model of prolonged critical illness is not neces-
sarily the exclusive result of feedback-inhibition by locally ele-
vated T3 levels. Other illness-related factors could be inferred
to suppress the TRH gene and the increased expression of
thyroid hormone transporters (MCT10 and OATP1C1) and of
D2 may reflect a compensatory response to a central hypothy-
roid state during prolonged critical illness.
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